Clinical trial / 2012
Daily multivitamin supplementation did not reduce major cardiovascular events in male physicians.
A randomized, double-blind trial followed 14,641 male US physicians aged 50 or older who received a daily multivitamin or placebo over a median of 11.2 years. Daily multivitamin use did not reduce major cardiovascular events (hazard ratio, 1.01; 95% CI, 0.91-1.10; P = .91). The supplement also showed no significant effect on myocardial infarction, stroke, cardiovascular mortality, or all-cause mortality.
- Study type
- Randomized controlled trial
- Who was studied
- 14,641 male US physicians aged 50 or older
- What was measured
- Major cardiovascular events and mortality
THE PAPER
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM. JAMA, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.